New technology for cancer treatment

July 2025

4 mins

Welcome to the Life Wisdom Show! Learn from experts who share their wisdom. In Episode 1, we explore the 'king of cancers' and the new painless and non-invasive treatments available in Hong Kong.

Video highlights:

Liver cancer, known as the "king of cancers," ranks among Hong Kong's five deadliest cancers. While uncommon, its mortality rate is very high. It shows little to no symptoms in the early stages, so most people only discover it when it's already advanced, making treatment much harder.
Hong Kong is the first city in Asia to offer a breakthrough treatment called Histotripsy. This method uses high-intensity ultrasound waves to break apart cancer cells, offering a lower-risk, painless, and non-invasive treatment for liver cancer.
Scientists in the United States are also testing Histotripsy on other cancers, such as brain cancer and breast cancer.
HSBC Life’s VHIS (Voluntary Medical Insurance Scheme) Flexi Plan offers full cover* for Histotripsy treatment giving you access to the latest medical advances. We regularly review and update our coverage so you're always protected by the better treatments.

*Full coverage refers to the actual amount of eligible expenses and other expenses that are charged and payable per the terms and benefits of this policy

Disclaimer

HSBC Life (International) Limited (incorporated in Bermuda with limited liability) ("HSBC Life", "the Company", "we” or "us”) is authorised and regulated by the Insurance Authority of the Hong Kong SAR to carry on long-term insurance business in the Hong Kong SAR. The Hongkong and Shanghai Banking Corporation Limited
("HSBC") is registered in accordance with the Insurance Ordinance (Cap. 41 of the Laws of Hong Kong) as an insurance agency of the Company for the distribution
of life insurance products in the Hong Kong SAR. Policyholders are subject to the credit risk of HSBC. For eligible disputes (as defined in the scope and jurisdiction
of the Financial Dispute Resolution Centre under the Financial Dispute Resolution Scheme) arising between HSBC and you out of the selling process or processing of the related transaction by HSBC, HSBC will enter into a Financial Dispute Resolution Scheme process with you. Any disputes arising from the terms, conditions and provisions of the abovementioned insurance policies will be resolved directly between you and the Company. For detailed information on the insurance products
offered by HSBC Life, please visit the insurance section of the HSBC website or any HSBC branch. The life insurance plans are products of the Company but not HSBC
or HSBC Life, underwritten by the Company and it is only intended for sale through HSBC in the Hong Kong SAR.

This material shall not constitute any kind of advice or recommendation on education or any other matters. Please do not rely on this document for making any kind of
decision. If you have any questions about the contents of this booklet, you should seek professional advice from independent parties. These contents represent general
information only, and do not constitute any suggestions or recommendations of any products. This material should not be reproduced or further distributed to any person or entities, whether in whole or in part, for any purpose.

Under any and all circumstances, HSBC Life and/or HSBC shall not be liable for any damages, losses or liabilities, including but not limited to direct or indirect,
special, incidental, consequential damages, losses or liabilities, in connection with your or any third party’s use of this booklet or your reliance on or use of or inability
to use the information contained in this booklet. All interviewees’ opinions are provided by the interviewees for reference only. They are not intended to constitute any
recommendation or advice to any persons or to be the basis for any financial decision. The opinions expressed are those of the interviewees and do not represent the
views of HSBC Life or HSBC.

Date